Moon Sungji, Choi Jeoungbin, Sung Soseul, Hong Youjin, Ko Kwang-Pil, Lee Jung Eun, Kim Inah, Ryu Seungho, Jee Sun Ha, Kim Guen Hui, Yang Sun Young, Shin Aesun, Kweon Sun-Seog, Kim Jeongseon, Jang Jieun, Lee Sangjun, Kim Kyungsik, Lim Woojin, Choi Yoon-Jung, Im Jeong-Soo, Seo Hong Gwan, Park Sue K
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Cancer Research Institute, Seoul National University, Seoul, Korea.
J Korean Med Sci. 2025 Jul 7;40(26):e143. doi: 10.3346/jkms.2025.40.e143.
To contribute to evidence-based cancer prevention policies, we conducted a systematic assessment to estimate the burden of infection-related cancers in South Korea. We estimated the population-attributable fraction (PAF) of each cancer attributable to the causally related infectious agents between 2015 and 2030.
The relative risks of cancer due to infectious agents were calculated using a meta-analysis of results from large-scale Korean cohort studies combined with results from a systematic review of South Korean studies. We calculated the attributable cancer incidence and mortality in 2015 and 2020 from nationwide cancer statistics, assuming a 15-year latency period, and projected them for 2025 and 2030.
The estimated attributable cancer cases were 28,420 (13.18%) in 2015 and 26,368 (10.70%) in 2020 for all new cancer cases due to infectious agents. Attributable cancer deaths were 11,292 (14.74%) in 2015 and 9,969 (12.15%) in 2020 for all new cancer mortalities. occupied the largest proportion of cancer incidence (5.93%), followed by hepatitis B virus (HBV) (2.45%) and human papillomavirus (HPV) (1.74%), and the first cause of cancer death was HBV (5.24%), followed by (4.62%) and HPV (1.41%) in 2020. The PAFs were predicted to decline to 9.35% (2025) and 8.99% (2030) for incidence, and to 10.18% (2025) and 10.02% (2030) for mortality.
Fractions of cancer cases and mortality due to infectious agents are projected to decrease from 2015 to 2030. There should be adequate intervention from authorities to control , HBV, and HPV and to reduce the cancer burden.
为了推动基于证据的癌症预防政策,我们进行了一项系统评估,以估算韩国感染相关癌症的负担。我们估算了2015年至2030年间每种癌症可归因于因果相关感染因子的人群归因分数(PAF)。
利用韩国大规模队列研究结果的荟萃分析以及韩国研究系统评价的结果,计算感染因子导致癌症的相对风险。我们根据全国癌症统计数据,假设潜伏期为15年,计算了2015年和2020年可归因的癌症发病率和死亡率,并对2025年和2030年进行了预测。
2015年,因感染因子导致的所有新发癌症病例中,估计可归因的癌症病例为28420例(13.18%),2020年为26368例(10.70%)。2015年,所有新发癌症死亡病例中,可归因的癌症死亡为11292例(14.74%),2020年为9969例(12.15%)。 在2020年占癌症发病率的比例最大(5.93%),其次是乙型肝炎病毒(HBV)(2.45%)和人乳头瘤病毒(HPV)(1.74%),癌症死亡的首要原因是HBV(5.24%),其次是 (4.62%)和HPV(1.41%)。预计发病率的PAF将在2025年降至9.35%,2030年降至8.99%;死亡率的PAF将在2025年降至10.18%,2030年降至10.02%。
预计2015年至2030年,因感染因子导致的癌症病例和死亡比例将下降。当局应进行充分干预,以控制 、HBV和HPV,并减轻癌症负担。